About Heart Congress 2020

MEC Global Events cordially invites all the participants its premier Global Heart Congress scheduled during July 30-31, 2020 Virtual Conference which includes major keynote presentations, plenary talks. Global Heart Congress 2020 designed to gather all the eminent in the field of cardiology and related areas.

Global Heart Congress 2020 will be focused mainly on the theme: Advancements in Heart Care & Treatments.

Why to Attend?

Heart Congress 2020 is the best opportunity for all the cardiology and heart related doctors, cardiology professionals, scientists, Radiologists, oncology professionals, electro physiologists, cardiac nurses, cardiology surgeons, Physicians, research scholars, students who are working in cardiology and its allied areas to explore their scientific research across the globe.

What are the Sessions?

  • Heart Diseases and Cardiovascular Disorders
  • Heart Failure and Myocardial infraction
  • Heart Diagnosis
  • Heart and Lung Transplantation
  • Cardiac Devices
  • Cardiovascular Research
  • Hypertension and Obesity
  • Pediatric Cardiology
  • Cardiac Nursing: Acute and Chronic Cardiac Care
  • Heart Regeneration and Stem Cell Research
  • Cardiovascular Pharmacology
  • Cardiology - Future Medicine
  • Clinical and Experimental Cardiology
  • Thoracic and Cardiac Surgery
  • Cardio Oncology and Nuclear Cardiology
  • Case Reports in Cardiology
  • Geriatric Cardiology
  • Current Research and Advances in Cardiology

Who can Attend?

  • Cardiology Faculty
  • Cardiology Researchers
  • Medical Professionals
  • Cardiology Associations and Societies
  • Research Scholars
  • Students
  • cardiac nurses
  • cardiology surgeons
  • Physicians
  • electro physiologists
  • Radiologists
  • Oncology Professionals
  • Business Entrepreneurs
  • Training Institutes
  • Software making associations
  • Data Management
  • Manufacturing Medical Devices Companies

Market Report:

The recent study on cardiology research market by reports and data says that market was estimated to gain a value of USD 69.08 billion by the end of 2026 with a CAGR of 6.8%. Most common heart diseases like stroke, hypertensive heart disease, heart arrhythmia, congenital heart diseases, rheumatic heart failure etc.

Total sales for cardiovascular disease drugs will grow steadily over the next six years, from almost $47 billion in 2018 to over $70 billion in 2024. The global cardiovascular therapeutics market continues to see rapid innovation with new drugs and devices entering the market. Asia-Pacific regional segment of the cardiovascular device market has registered a very high CAGR. This can be attributed the rising population, especially the geriatric, adoption of unhealthy western lifestyle and heavy investments in health sector. Among the devices for Diagnostic and Monitoring, the ECG holds at least 40% of the share, this can be attributed to the augmented capacities of the new generation electrocardiograms. The market being consolidated and restricted to a few very strong key players, the market situation is very difficult for the entrants especially for entrants to get tax cuts and product approvals.